
Elixxer Ltd
ELXR · V · Healthcare / Drug Manufacturers - Specialty & Generic
0.03CAD+0.00 (0.00%)
Price History
Full chartMarket Stats
Previous Close0.03
Open0.03
Day Range0.03 – 0.03
52-Week Range0.03 – 1.15
Volume0
Market Cap13.05M
P/E (TTM)0.00
Forward P/E0.00
EPS-1.02
Dividend Yield0.00%
Beta0.87
50-Day Avg1.15
200-Day Avg1.15
About
Elixxer Ltd. operates as a cannabis investment firm in Canada, Australia, Italy, Jamaica, and Switzerland. It invests in cultivation, production, and/or sale of medical cannabis and cannabis-derived products in the pharmaceutical sector. The company was formerly known as LGC Capital Ltd. and changed its name to Elixxer Ltd. in August 2019. Elixxer Ltd. was incorporated in 2004 and is based in Montreal, Canada.
Company Details
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CEOMr. Ferras Zalt
- Employees0
- Headquarters1100 Boulevard Rene- Levesque Ouest, Montreal, QC, Canada, H5B 4N4, Canada
- Websitehttps://www.elixxer.com
Leadership
- Mr. Ferras ZaltChairman & Interim CEO · b. 1963
- Ms. Kym No C.M.A., CPACorporate Controller & Interim CFO
- Mr. Guy Charette L.L.B., LL.B.Legal Council · b. 1954
- Ms. Jeanne van WykVice President of Communications
- Mr. Daniel LubienietzkyVP of Corporate Development
- Mr. Richard WidmannEVP of Commercial · b. 1968
- Mr. Michael KozubCorporate Secretary
Financials
Income Statement
Balance Sheet
Cash Flow
Earnings
Key Statistics & Ratios
Market Cap13.05M
Enterprise Value21.92M
Trailing P/E0.00
Forward P/E0.00
Price / Sales767773.80
Price / Book2.67
EPS-1.02
Book Value-0.757
Revenue (TTM)17
Gross Profit (TTM)42.41K
EBITDA-2.50M
Profit Margin0.00%
Operating Margin-15406094.00%
Return on Equity-1013.76%
Return on Assets-30.42%
Shares Outstanding11.34M
Shares Float11.05M
Beta0.87
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%
Stock Splits
- Feb 10, 20221:100
- Jul 19, 20161:1.278